I
Intralytix, Inc.
Intralytix, Inc. is a biotechnology company focused on the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical…
About Intralytix, Inc.
Intralytix is a pioneering biotechnology company based in Columbia, MD, specializing in the development and commercialization of bacteriophage-based products. Bacteriophages, or phages, are viruses that specifically target and kill bacteria, offering a natural and highly effective solution for bacterial contamination. The company operates primarily in the food safety and human health markets, providing products that enhance food processing safety, prevent food spoilage, and treat bacterial infections in both humans and animals.
Intralytix serves a diverse range of clients, including food processors, agricultural businesses, and healthcare providers. The company's business model revolves around the research, development, and sale of bacteriophage products. Revenue is generated through direct sales of these products, as well as through partnerships and licensing agreements with other companies in the biotechnology and healthcare sectors.
The market for bacteriophage-based solutions is growing, driven by increasing concerns over antibiotic resistance and the demand for safer, more natural antimicrobial treatments. Intralytix is well-positioned to capitalize on this trend, leveraging its expertise in phage technology to offer innovative and effective solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Columbia, United States
- Employees
- 34
- Open positions
- None listed
- Dealroom signal
- 34.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Food Processing, Biotechnology, Agritech, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Jun 2026 | $0 | — | National Institutes of Health | ↗ |
| GRANTOther financing | May 2020 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Intralytix, Inc. is 2.4K monthly website visits, down 27.3% over the last three months. Intralytix, Inc.'s team declined 2.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Lesaffre
National Institutes of Health
Other known investors3 additional known investors
University of Maryland School of Medicine
University of Maryland, Baltimore (UMB)
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Intralytix, Inc. on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Intralytix, Inc.’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.